Alzheimer’s disease and Parkinson’s disease are not the same. They affect different regions of the brain and have distinct genetic and environmental risk factors. But at the biochemical level, these two neurodegenerative diseases start to look similar. That’s how Emory scientists led by Keqiang Ye, PhD, landed on a potential drug target for Parkinson’s. In...
Tag: <span>Alzheimers</span>
Post
Extra virgin olive oil staves off Alzheimer’s, preserves memory, new study shows
Temple University research shows extra-virgin olive oil protects against memory loss, preserves the ability to learn and reduces conditions associated with Alzheimer’s disease. Researchers at the college’s Lewis Katz School of Medicine found mice with EVOO-enriched diets had better memories and learning abilities compared to the rodents who didn’t eat the oil. The real effect...
Post
Detecting Alzheimer’s disease earlier using … Greebles?
Unique graphic characters called Greebles may prove to be valuable tools in detecting signs of Alzheimer’s disease decades before symptoms become apparent. In an article published online last week in Journal of Alzheimer’s Disease, Emily Mason, Ph.D., a postdoctoral associate in the Department of Neurological Surgery at the University of Louisville, reported research showing that...
Post
X-Rays Of The Earliest Stage Of Alzheimer’s Offer Critical Clue About How It Starts
Scientists peered into the brains of mice and saw something about Alzheimer’s they hadn’t seen before. As many as 5 million Americans are living with Alzheimer’s disease today, and that number could more than triple by 2025. The brain disorder is the most common form of dementia, causing memory loss that worsens over time and eventually pushes the...
Post
Cannabis Can Help Cure Alzheimer’s If Lawmakers Are Flexible: Experts
Cannabis holds great promise in treating dementia and Alzheimer’s disease. But the opportunity is being allegedly blocked by the federal regulators in the United States, according to researchers. Reports say that California’s Salk Institute is facing legal hurdles in advancing the research in cannabis cure. Their goal is to offer an effective treatment for these fatal diseases...
Post
From Alzheimer’s to autism, nuclear neurology could launch revolution in diagnosing and treating brain diseases
Image of glucose metabolism PET overlaid on CT in an Alzheimer’s patient with mild dementia. Green arrow points to regional hypometabolism in the medial parietal lobe, (which processes biographical information and memory),a proposed biomarker for Alzheimer’s. UB researcher with database of 16,000 brain scans proposes that powerful imaging can transform neurology as it did cardiology...
Post
Researcher uses wearable devices to look for clues to early Dementia and Alzheimer's
In 2014, more than 93,000 people in the United States died from Alzheimer’s disease, according to the Centers for Disease Control and Prevention. The complex nature of Alzheimer’s makes it difficult to understand and predict, until it’s too late. Boston University professor and neuropsychologist Rhoda Au is trying to change that. Through the use...
Post
Scientists develop AI-based method to diagnose Alzheimer's or Parkinson's
Alzheimer’s disease, which currently affects more than 40 million people, is the most common neurodegenerative disease in elder people. Alzheimer’s disease, which currently affects more than 40 million people, is the most common neurodegenerative disease in elderly people. Early diagnosis is crucial both to treat the disease and to help the development of new...
Post
Action of "gatekeeper" cells could be ground zero for Alzheimer's
A new pathway in to preventing and treating Alzheimer’s? In the hunt for a cause and cure for Alzheimer’s disease and other neurodegenerative ailments, much attention has been focused on sticky proteins called beta-amyloid plaques that build up in the brain and cause nerve damage. A new potential target has been identified by researchers however, in...
Post
Scientists Are Reversing the Symptoms of Alzheimer’s
IN BRIEF The testing of injecting RNA into Alzheimer’s patients to reduce the levels of tau proteins is a possible new treatment for the more than 5.1 million people living with Alzheimer’s. The treatment has shown some limitation in the testing done on chimps, more testing will be done on primates to discern the safety...